Crohn's Disease Market

Crohn's Disease Market - Global Industry
Analysis, Size, Share, Growth, Trends, and
Forecast 2017 - 2025
Transparency Market Research Reports incorporated a definite
business overview and investigation inclines on "Crohn's
Disease Market". This report likewise incorporates more
illumination about fundamental review of the business including
definitions, requisitions and worldwide business sector industry
structure.
Crohn's disease is a prolonged inflammatory disease of the
bowel, affecting any part of the gastrointestinal tract, i.e. from
the mouth to the anus. Crohn's disease is frequently diagnosed in
two different age groups, first between 15 and 35 years old and
second between 60 and 80 years old. The disease is mainly
characterized by abdominal pain, diarrhea (with or without
blood), fever, and weight loss.
Additionally, extraintestinal conditions such as arthritis,
erythema nodosum, and uveitis are detected among half of the
patients. Prevalence and incidence of Crohn's disease is rising
globally since the last few years. The exact cause of Crohn's
disease is not recognized; however, some factors such as genetic
malfunctions concerning the immune system concurrent with
some environmental factors such as normal flora of human gut,

smoke, foods, chemical contamination, or pollution triggers the
occurrence of Crohn’s disease in susceptible people.
Browse Full Research Report on Crohn's Disease Market:
http://www.transparencymarketresearch.com/crohns-diseasemarket.html
The global Crohn’s disease market is driven by increasing
incidence of bowel disorders such as Crohn’s disease, leading to
drug innovations for treatment. Crohn’s disease is more
prevalent in developed and industrialized countries, particularly
in individuals who smoke, and also with changing food habits,
such as preference of fast food over vegetables and fruits.
Therefore, rising patient population due to lifestyle changes and
other factors also contributes to the expansion of the market.
Furthermore, rising demand for biologics for treatment of bowel
disorders such as Crohn’s disease, increasing awareness about
Crohn’s disease, and the available treatments are estimated to
propel the global market. Additionally, drug manufacturers are
vigorously focusing on innovative products having more
efficiency. Therefore, increased preference and utilization for
anti-inflammatory drugs and biologics coupled with the rising
acceptance of biosimilars is anticipated to play a significant role
in boosting the Crohn’s disease market during the forecast
period.

Therefore, the Crohn’s disease market is projected to witness
key trends such as increased preference for symptomatic drugs
and therapeutic over surgeries, better disease management for
inflammatory bowel diseases like Crohn’s disease, and the
arrival of improved drugs in the market due to better
investments in R&D programs, prevailing the market. However,
high cost of treatment is likely to be a major restraint for the
market. Moreover, lack of early diagnosis, mostly in developing
countries, and the patent expiry of blockbuster drugs may
hamper the expansion of the market in the near future.
The global Crohn’s disease market can be segmented into
diagnosis, drug type, and region. Crohn’s disease can be
diagnosed by blood test, colonoscopy, capsule endoscopy,
sigmoidoscopy, small bowel imaging, double-balloon
endoscopy, computerized tomography (CT), and magnetic
resonance imaging (MRI). In terms of drug type, the market can
be segmented into anti-diarrheal, antiinflammatory drugs,
immuno suppressors, antibiotics, and pain relievers.
In terms of geography, the Crohn’s disease market can be
segmented into North America, Europe, Latin America, Asia
Pacific, and Middle East & Africa. North America dominates the
global Crohn’s disease market. Major share of the region is
attributed to the significant incidence of Crohn’s disease in the
region, mainly Canada and the US (Ranjbar et. al. 2015),
unhealthy life style including fast food consumption and

smoking habits, progressive healthcare infrastructure and
innovative healthcare solutions.
Europe follows North America in terms of share of the global
Crohn’s disease market. The Crohn’s disease market in Asia
Pacific is projected to expand at a high growth rate. This rise is
primarily due to changing food habits, industrialization, and
innovative diagnostic and treatment options for the disease.
Major players in the market find countries in Asia to be
productive markets for Crohn’s disease with the increasing
incidence of the disease in the countries in the region. They are
making significant investments, which in turn is likely to fuel
the expansion of the market in the region.
Key players operating in the global Crohn’s disease market
include AbbVie Inc., Allergan, Inc., Bayer AG, Bristol-Myers
Squibb, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche,
Eli Lilly and Co., GlaxoSmithKline plc, Janssen Biotech, Inc.,
Johnson & Johnson, Novartis International AG, Pfizer Inc.,
Sanofi, and Takeda Pharmaceutical Company Limited.

About Us
Transparency Market Research (TMR) is a global market
intelligence company providing business information reports
and services. The company’s exclusive blend of quantitative
forecasting and trend analysis provides forward-looking insight
for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants use proprietary data
sources and various tools and techniques to gather and analyze
information.
TMR’s data repository is continuously updated and revised by a
team of research experts so that it always reflects the latest
trends and information. With extensive research and analysis
capabilities, Transparency Market Research employs rigorous
primary and secondary research techniques to develop
distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com